March 15, 2013
A Tennessee magistrate judge on Thursday barred plaintiffs from bringing medical expense claims in 46 cases that are part of multidistrict litigation against Novartis Pharmaceutical Corp. over injuries allegedly caused by bone drugs Aredia and Zometa, saying they'd failed to comply with discovery requests.
August 03, 2012
A Tennessee magistrate judge kicked off a discovery overhaul Friday in multidistrict litigation against Novartis Pharmaceutical Corp. over injuries allegedly caused by bone drugs Aredia and Zometa, days after the court revamped a bellwether system to speed up the litigation.
October 20, 2011
A federal judge on Monday levied roughly $55,000 in sanctions against Novartis Pharmaceuticals Corp. in a multidistrict litigation over allegedly concealed health risks associated with two bone cancer drugs, while saying the plaintiffs' requested attorneys' fees were needlessly high.
May 20, 2011
Novartis Pharmaceuticals Corp. asked a Tennessee federal judge on Thursday to exclude six experts' testimony in 30 suits in a multidistrict litigation over the bone cancer drugs Aredia and Zometa, the same day it sought to dismiss four of those cases.
December 08, 2010
A federal judge has tossed two suits and nixed strict liability and negligence claims from six other cases in multidistrict litigation accusing Novartis Pharmaceuticals Corp. of failing to warn patients that bone cancer drugs Aredia and Zometa could cause their jawbones to deteriorate.